Chronic Thromboembolic Pulmonary Hypertension: An Update
Open Access
- 19 January 2022
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 12 (2), 235
- https://doi.org/10.3390/diagnostics12020235
Abstract
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare disease observed in a small proportion of patients after acute pulmonary embolism (PE). CTEPH has a high morbidity and mortality rate, related to the PH severity, and a poor prognosis, which mirrors the right ventricular dysfunction involvement. Pulmonary endarterectomy (PEA) reduces pulmonary vascular resistance, making it the treatment of choice and should be offered to operable CTEPH patients, as significant symptomatic and prognostic improvement has been observed. Moreover, these patients may also benefit from the advances made in surgical techniques and pulmonary hypertension-specific medication. However, not all patients are eligible for PEA surgery, as some have either distal pulmonary vascular obstruction and/or significant comorbidities. Therefore, surgical candidates should be carefully selected by an interprofessional team in expert centers. This review aims at making an overview of the risk factors and latest developments in diagnostic tools and treatment options for CTEPH.This publication has 107 references indexed in Scilit:
- Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertensionHeart, 2013
- Percutaneous Transluminal Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary HypertensionCirculation: Cardiovascular Interventions, 2012
- Refined Balloon Pulmonary Angioplasty for Inoperable Patients with Chronic Thromboembolic Pulmonary HypertensionCirculation: Cardiovascular Interventions, 2012
- Pulmonary Hypertensive Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension Before Pulmonary ThromboendarterectomyJournal of the American College of Cardiology, 2009
- Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a Randomized, Placebo-Controlled TrialJournal of Invasive Cardiology, 2008
- Risk factors for chronic thromboembolic pulmonary hypertensionEuropean Respiratory Journal, 2008
- Incidence of Chronic Thromboembolic Pulmonary Hypertension After a First Episode of Pulmonary EmbolismSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2006
- Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and DiseasePhysiological Reviews, 2004
- High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertensionThrombosis and Haemostasis, 2003
- Pulmonary thromboendarterectomy – risk factors for early survival and hemodynamic improvementEuropean Journal of Cardio-Thoracic Surgery, 2001